Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AHDC1 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | ATIC | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
mRNA | ST8SIA5 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | CDKN1A | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | RP4-613B23.5 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
mRNA | MEGF11 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
mRNA | GNG2 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
mRNA | PRSS57 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
mRNA | SLC35A5 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
mRNA | MGRN1 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |